Drug and Alcohol Dependence

Article	Citations
Letter to the Editor regarding: Is implementation of ASAM-based addiction treatment assessments associated with improved 30-day retention and substance use? (By Mark et al., 2021)	295
A novel long-acting formulation of oral buprenorphine/naloxone produces prolonged decreases in fentanyl self-administration by rhesus monkeys	224
Development and validation of the Schedule for the Assessment of Insight in Alcohol Dependence (SAI-AD): Dimensions and correlates of insight in alcohol use disorder	130
Editorial Board	120
Editorial Board	101
Access to methadone clinics and opioid overdose deaths in Georgia: A geospatial analysis	93
EFFECTS OF SOCIAL DEFEAT STRESS EXPOSURE ON SPATIAL MEMORY PERFORMANCE IN SOCIALLY MONOGAMOUS MALE PRAIRIE VOLES	92
EXPLORING ASSOCIATIONS BETWEEN TRADITIONAL GENDER NORMS AND PRE-IMMIGRATION SEXUAL RISK BEHAVIORS AMONG MALE & FEMALE RECENT LATINO/A IMMIGRANTS	87
SEX AND GENOTYPE DEPENDENT DRUG-INDUCED DOPAMINE RELEASE IN ADOLESCENT CHRNA6 3’-UTR RATS	73
Does substance use disorder treatment completion reduce the risk of treatment readmission in Chile?	69
Neighborhood disadvantage and prescription drug misuse in low-income urban mothers	67
Corrigendum to “Predictors of enrollment in opioid agonist therapy after opioid overdose or diagnosis with opioid use disorder: A cohort study” [Drug and Alcohol Dependence 219 (2021) 108435]	62
A randomized pilot trial of two forms of behavioral economics intervention to improve engagement in buprenorphine-naloxone treatment among patients with opioid use disorder	61
Correlates of solitary alcohol and cannabis use among American Indian adolescents	60
Effects of access condition on substance use disorder-like phenotypes in male and female rats self-administering MDPV or cocaine	58
Ethnic density effect on alcohol-related hospitalizations among Chinese enclaves and ethnoburbs in California, 2007–2011	55
Social addiction or nicotine addiction? The effect of smoking social motivation on inhibitory control under smoking social cues: Evidence from ERPs	54
Corrigendum to “Longitudinal latent class analysis of tobacco use and correlates among young adults over a 10-year period” [Drug Alcohol Depend. 236 (2022) 109474]	52
The moderating role of resilience in the relationship between experiences of COVID-19 response-related discrimination and disinformation among people who inject drugs	51
Impact of the Russian invasion on opioid agonist therapy programs in Ukraine: A qualitative study	51
Validation of a single question for the assessment of past three-month alcohol consumption among adolescents	49
Socioeconomic inequalities in alcohol consumption in Argentina: Comparative analysis from 2009, 2013, and 2018	49
The effects of combination levodopa-ropinirole on cognitive improvement and treatment outcome in individuals with cocaine use disorder: A bayesian mediation analysis	48
Comparing Racial and Ethnic Differences on Access to Wellness Services for People in Substance Use Treatment	46
Use of laboratory data for illicit drug use surveillance and identification of socioeconomic risk factors	46

Sex Differences in Contextual Cocaine Seeking Behavior are Driven by Noradrenergic Signaling to the Dorsal Hippocampus	45
Receiving Medications for Opioid Use Disorder in Maryland Correctional Facilities and at a Community-Based Low-Threshold Buprenorphine Program Post-Release: Patient and Staff Perspectives	45
Risky Polysubstance Use Among People who Use Opioids in a Community-Based Study	44
Misuse Potential of Medicinal Ketamine in Real-World Clinical Contexts, Part 1: Patients With At-Home Prescribed Ketamine	44
UTILIZING INNOVATIVE APPROACHES TO ENHANCE THE FULL POTENTIAL OF SUBSTANCE USE DATA TO BENEFIT MINORITIZED POPULATIONS	44
Guanfacine Reduces Drug Craving, Stress and Increases the Number of Abstinence Days in Women With Polysubstance Use Disorder (PSUD): A Pilot 2-Site Clinical Study	43
BRIDGING THE GAP: PRACTICAL AND ETHICAL CONSIDERATIONS ON THE UTILITY OF ARTIFICIAL INTELLIGENCE IN SUBSTANCE USE DISORDERS	42
Clinical Translation of the HR/LR Model of SUD Propensity	42
Evaluation of Antidepressant and Anxiolytic Effects of Medicinal Cannabis Use via Ecological Momentary Assessments	40
Provider Perspectives on Child Protective Services Reporting for Perinatal Patients With Opioid Use Disorder	40
Beyond Rest: Unraveling the Nexus of Sleep Deficiency, Environment, Control, and their Influence on Opioid Use Disorder Treatment Outcomes	39
Adolescent Gender Diversity and Substance Use Exposure: A Mediating Role of Peer Victimization	39
The Association between Poly-victimization and Opioid Misuse Among Justice-Involved Adolescents	38
Characterizing Substance Use Disorder on Reddit Through Network Analysis and Transitions of Use Between Opioids, Cannabis, and Other Drugs	37
Chronic Oral Dosing of Cannabidiol (CBD) With and Without low Doses of Delta-9-Tetrahydrocannabinol (Δ-9-THC)	37
The Effects of Acupuncture Stimulation at Shenmen (HT7) on Brain Stimulation Reward in Rats	37
Factors Associated With Self-Directed Discharge Among Hospitalized Individuals With a Substance Use Disorder	36
Development of the Subject-Rated Comprehensive Drug Withdrawal Scale (CDWS) to Evaluate the Physical Dependence Potential of Investigational Drugs	36
Racial and Ethnic Disparities in Telehealth and Emergency Department Use Among Women With Substance Use Disorder during the COVID-19 Pandemic	36
Determination of Yohimbine's Reinforcing Actions in Male and Female Rats	36
A Comparative Study of Behavioral Effects of Novel Designer Drugs in Male Rodents	36
Denial of Prescription Pain Medication Among People Who Use Drugs in Vancouver, Canada	35
Pharmacology of Newer Synthetic Cannabinoids at the CB1 Receptor	34
Risk of COVID-19 Hospitalization and Death in Patients on Chronic Opioid Therapy and With Opioid Use Disorder	34
Comparative Effectiveness of Intranasal Naloxone and Nalmefene in a Translational Model Assessing Reversal of Cardiac Arrest Induced by Synthetic Opioid Overdose	34
Assessment of the Publication Trends of the Harm Reduction Studies over 40 Years	34
Nalfurafine is Aversive at Analgesic Doses - Non-Clinical Evidence to Indicate It is Not an Atypical Kappa Opioid Receptor Agonist	34
Avoidance of Racial Trauma Exposure and Concurrent Substance Use Among Racial/Ethnic Minoritized Young Adults	34
More Stress Than You Know: A Qualitative Study of Client Experiences Navigating MOUD Treatment	33
A Pilot Study of 16-Week Intensive Outpatient Treatment for Gay and Bisexual Men With Methamphetamine Use Disorder in Taiwan	33
XYLAZINE: AN ADULTERANT DRUG OF CONCERN	33
TERPENE AND CANNABINOID PROFILE PREFERENCES AND CANNABIS USE PRACTICES IN MEDICAL CANNABIS PATIENTS WHO USE CANNABIS FOR PAIN AND ANXIETY	33
How Common is Fentanyl Contamination of Methamphetamine? Attitudes, Self-Reported Exposures, and Toxicology Data From Persons who Use Methamphetamine	32
A Novel 3mg Naloxone Nasal Spray for the Over-the-Counter Market	32
A Novel Hand-Held Personalized Dual Biometrically Controlled Device for At-Home Dispensation of Methadone	32
Post-Stress Late Positive Potential Prospectively Predicts Cannabis Use Disorder Severity in Cannabis Using Women	32
Preferences for Abstinence-Based Recovery and Public Stigma Toward Substance Use	32
Perceived Stigma on the Emotional Wellbeing Among Latinx With Substance Use Disorders: The Mediated Roles of Self-Stigma and Self-Efficacy	32
Associations between right inferior frontal gyrus morphometry and inhibitory control in individuals with nicotine dependence	31
Ethical and Methodological Challenges in Studying Discontinuation of Medications for Opioid Use Disorder	31
Relationship perceptions and conflict behavior among cannabis users	31
Treatment Engagement, Cigarette Smoking, and Quit Attempts one Month After a Randomized Controlled Trial of E-Cigarette Reduction Among Dual Users	31
SYMPOSIUM: 10 YEARS GONE: REMEMBERING BILL WOOLVERTON THROUGH HIS IMPACT ON OUR CURRENT RESEARCH PROGRAMS	31
Cannabis use and subjective response to alcohol in the human laboratory	30
Long-term opioid therapy tapering: Trends from 2014 to 2018 in a Midwestern State	30
The opioid epidemic in rural communities: Can telehealth increase access to medications for opioid use disorder and offset barriers to care?	30
Drug use and needle sharing among adolescents and young adults in Nigeria: A cross-sectional secondary analysis of data from a multi-site clinical trial	29
Pilot randomized trial of cognitive-behavioral treatment plus contingency management for quitting smoking and weight gain prevention among smokers with overweight or obesity	29
Genetic Insights into the causal relationship between cannabis use and diabetic phenotypes: A genetic correlation and Mendelian randomization study	29
Health care provider decision-making around prenatal substance use reporting	29

The use of Australian SMART Recovery groups by people who use methamphetamine: Analysis of routinely-collected nationwide data	29
Types of criminal legal system exposure and polysubstance use: Prevalence and correlates among U.S. adults in the National Survey on Drug Use and Health, 2015–2019	29
Varenicline and related interventions on smoking cessation: A systematic review and network meta-analysis	28
Why do Americans use marijuana?	28
Prescription opioid use and employment: A nationwide Finnish register study	28
Reduced neural functional connectivity during working memory performance in methamphetamine use disorder	28
Screening in Trauma for Opioid Misuse Prevention (STOMP): Results from a prospective cohort of victims of traumatic injury	28
Worsening trends in the frequency of methamphetamine and other stimulant use between treatment admission and discharge	27
Receipt of opioid use disorder treatments prior to fatal overdoses and comparison to no treatment in Connecticut, 2016–17	27
Generational shifts in attitudes and beliefs about alcohol: An age-period-cohort approach	27
Trends in homelessness and injection practices among young urban and suburban people who inject drugs: 1997-2017	27
The centrality of craving in network analysis of five substance use disorders	27
Disclosure processes as predictors of relationship outcomes among people in recovery from opioid use disorder: A longitudinal analysis	27
Exploring the relationship between sleep disturbances and cannabis use outcomes among Hispanic/Latino young adults	26
Methodological considerations when assessing symptoms of nicotine dependence by cigarette and e-cigarette use behavior and brand	26
Characterizing Empirically-Derived Sub-Groups of Latinx PWID Living Along the U.S.-Mexico Border for HIV and HCV Prevention	26
CULTURALLY RESPONSIVE TRAINING TO PRACTITIONERS: REDUCING MENTAL HEALTH DISPARITIES AMONG HISPANIC AND LATINOS	26
Effects of very low nicotine cigarettes, e-cigarettes, and nicotine patches on daily own-cigarette abstinence in a randomized controlled switching trial	26
CHARACTERIZING MULTISYSTEM STIGMA: EXAMINING ITS ADVERSE IMPACT ON MOTHERS' ENGAGEMENT AND RETENTION IN RESIDENTIAL SUD TREATMENT	26
VAGINAL INSTABILITY AND DYSBIOSIS IS PREVALENT AMONG HISPANIC WOMEN LIVING IN PUERTO RICO REGARDLESS OF BODY MASS INDEX	26
Dose by design: How limits on nicotine flux and puff duration affect the abuse liability of electronic nicotine delivery systems	26
Rates of Medication Prescription, Mental Health Disorder, and HCV Diagnoses Among Patients With Comorbid Alcohol and Opioid Use Disorder in Rural Primary Care Clinics	25
DEPRESSION SCREENING AMONG PERINATAL PATIENTS WITH AND WITHOUT SUBSTANCE USE DISORDERS FOLLOWING IMPLEMENTATION OF A COLLABORATIVE CARE PROGRAM	25
THE FAMILIAR TASTE OF POISON: A QUALITATIVE STUDY OF MULTI-LEVEL MOTIVATIONS FOR STIMULANT USE IN SEXUAL MINORITY MEN LIVING IN SOUTH FLORIDA	25
SUVOREXANT, AN FDA-APPROVED DUAL OREXIN RECEPTOR ANTAGONIST, EFFECTIVELY REDUCES OXYCODONE SELF-ADMINISTRATION AND CONDITIONED REINSTATEMENT IN MALE AND FEMALE RATS	25
NIAAA Update Presented by George Koob, Director of the National Institute on Alcohol Abuse and Alcoholism	25
GABAPENTIN UTILIZATION AMONG BUPRENORPHINE-PRESCRIBED INDIVIDUALS WITH OPIOID USE DISORDER AND ASSOCIATED RISK OF OVERDOSE	25
RECENT INCARCERATION, SUBSTANCE USE, OVERDOSE, AND TREATMENT AMONG RURAL PEOPLE WHO USE DRUGS	25
Syndemic Profiles and Opioid-Related Mortality Among People Initiating Chronic Episodes of Prescription Opioid Use in BC, Canada	24
Brandeis/Harvard Spire Center: SUD Systems Performance Improvement Research and Engagement	24
Substance Co-Exposure Among Women With Opioid Use During Pregnancy	24
Domestic Cannabis Cultivation: Results of the Georgian (country) Sample of the Transnational Online Survey of Cannabis Growers	24
Perceptions of Racism’s Impact on Drug Use Among African Americans Using Opioids	24
Extended-Release Mixed Amphetamine Salts for Comorbid Adult Attention-Deficit/Hyperactivity Disorder and Cannabis Use Disorder: A Pilot, Randomized Double-Blind, Placebo-Controlled Trial	24
Factors Associated With Risk for Cannabis Use Disorder Among Adults Using Medical Marijuana in Florida	24
Primary Form of Cannabis Use and Recent Negative Affect Symptoms	24
Disparities in the Hepatitis C Virus Cascade of Care Among Reproductive Age Women With Opioid Use Disorder	23
Psychosocial and Drug Use Characteristics in Persons With Opioid Use Disorder and Chronic Pain	23
Optimizing Recovery Funding: Barriers to Acquiring Funding Among Organizations in the Ecosystem of Recovery	23
Outcomes of the Community-Based Medication-First Program for Opioid Use Disorder: A Multisite Hybrid Implementation Study	23
Common and Distinct Associations Between Baseline Impulsivity and Longitudinal Development of Positive and Negative Alcohol Expectancies in the Adolescent Brain Cognitive Development (ABCD) Cohort	23
Sex Differences in the Prospective Association of Intra-Individual Reaction Time Variability in Stroop and Hazardous Cannabis Use at Six Months	23
Self-Perception of Smoking Status and Co-Use of Cannabis and Narcotic Pain Medication	23
Cannabis Use Effects on Reaction Time in Daily Versus Occasional Users	23
Performance of a Brief Substance Use Symptom Checklist (SUSC) for Identifying Substance Use Disorder Among Primary Care Patients With or at Elevated Risk for Opioid Use Disorder	23
Characterization of Peer Support Services for Substance Use Disorders in 11 U.S. Emergency Departments in 2020: Findings From a Nida Clinical Trials Network Study Site Selection Process	23
Behavioral and Psychosocial Predictors of Cannabis Use Among Youth During the COVID-19 Pandemic	23
Prospective association between screen use modalities and substance use experimentation in early adolescents	22
A Randomized Controlled Six-Way Crossover Study to Characterize the Nicotine Pharmacokinetics of a Novel Oral Nicotine Pouch Product	22
Examining the effect of prescription drug monitoring program integration and mandatory use policies on the distribution of methadone and buprenorphine for opioid use disorder, United States, 2009–2021	22
Treatment Outcomes From Computerized CBT for Substance Use Disorders Among People With Criminal Justice Involvement	22
Stakeholder preferences for supervised consumption site design, staff, and ancillary services: A scoping review of feasibility studies	22
Latent profiles of impulsivity facets and associations with drinking behaviors	22
Barriers and Facilitators to Injectable Opioid Agonist Treatment Engagement: A Qualitative Study of Patient Experiences in Vancouver, Canada	22
MEDIA FORUM	22
Hepatitis C virus cascade of care among people who inject drugs in Australia: Factors associated with testing and treatment in a universal healthcare system	22
Editorial Board	22
Alcohol use in firefighters: A network model of behaviors and transdiagnostic risk	22
Modes of Cannabis Administration and Their Associations With Binge Drinking Among 12th Grade Students in the United States: A Cross-Sectional Analysis from 2018-2021	21
The Association Between Sleep Health and Multiple Tobacco Product Use Among Low-Income Smokers	21
Real-World Abuse-Related Data for a Schedule Ii Serdexmethylphenidate and Dexmethylphenidate (SDX/d-MPH) Drug Product Suggests Low Rates of Abuse	21
Mental Health Care Barriers for Women Involved in the Criminal Legal System With Substance Use Disorders: A Qualitative Study	21
Oral Oxycodone Self Administration in Rats With a History of Responding under a Multiple Schedule for Ethanol and Food or Oxycodone and Food	21
Methodology for Single- vs Polydrug Classification of Poisoning Deaths	21
Beyond Euphoria: Transcriptomic Investigation in the rat Brain Under the Administration of Fentanyl Combined With Xylazine	21
SUBSTANCE USE DISORDERS AND ASSOCIATED MEDICAL CONSEQUENCES: IMPLICATIONS FOR PREVENTION AND TREATMENT	21
Pregnancy Rates Among Women Treated With Medication for Opioid Use Disorder	21
Perceptions of the Combining HIV Services and Microenterprise for Sustainable Recovery (CHIMES) Intervention for Sober House Residents in Tanzania: A Qualitative Study	21
APP-BASED CONTINGENCY MANAGEMENT TO REDUCE HEAVY DRINKING DAYS AMONG SMOKERS RECEIVING VARENICLINE: FINDINGS FROM A WITHIN-SUBJECT A-B-A DESIGN TRIAL	21
Differences in Methamphetamine Use and Self-Reported Impact by Gender and Sexual Orientation in a Multisite U.s. Cohort of People with Hiv in Care	21
Sex Differences in Lifetime Non-Medical Prescription Opioid and Cannabis Use Among Older Adults in the All of Us Research Program	21
Naloxone Stigma Among People With Substance Use Disorder: Characteristics and Associations With Stigma toward Medication for Opioid Use Disorder (MOUD)	21
Why Do Medical Cannabis Patients use Illicit Medicinal Cannabis in the State of Utah?	20
Provision of Recovery Support Services in Opioid Use Disorder (OUD) Treatment Settings: A Secondary Data Analysis of the National Survey of Substance Abuse Treatment Services (N-SSATS) Data	20
Perceptions of Cannabis and its Associations With Mental Health Amongst Budtenders in Southern Ontario	20
A Qualitative Analysis of Individual, Relationship, and Community Factors Influencing Non-Initiation of Medications for Opioid Use Disorder During Incarceration	20
Impact of the Sudden Closure of Mexico’s Only Methadone Manufacturing Plant on the Mental, Financial and Social Health of Patients With Opioid Use Disorder (OUD) in Tijuana, Mexico	20
Causally Linkage of Adolescent Behavioral Anomalies to Prenatal Opioid Exposure	20
Qualitative Exploration of Opioid Overdose Response Steps Among Women Who Use Drugs on the Rural Eastern Shore of Maryland	20
Experiential Smoking Urges and Nicotine Withdrawal Reduction Among People Under Community Corrections Supervision Enrolled in In Vivo NRT Counseling	20

“Icy” Flavor Components in E-cigarette Images: Influence on Liking and Intention to Use Among Youth Who are Susceptible to E-cigarette Use	20
Pregnenolone Effects on Cocaine Use in Individuals with Cocaine Use Disorder	20
Associations Between Interoceptive Control of Avoidance and Patterns of Morphine Self-Administration	20
Characterizing Online Questions and Answers about Cannabis Use and Pregnancy: Data Mining and Content Analysis on the Social Media Platform Quora	20
Within-Subject Evaluation of Technology-Assisted Buprenorphine Treatment	20
“I Feel like People Would Look at Me like I’m Dirty or like I’m a Thief:” a Qualitative Exploration of Internal Experiences that Influence Recovery Among Adults at Risk of Opioid-Related Overdose	20
Conducting Community-Based Research on Substance Use in Rural Canada: Ethical and Methodological Considerations for Future Research	19
Pharmacist Involvement in Motivational Interviewing Intervention for Patients with Prescription Opioid Misuse Behaviors	19
Racialized Differences in the Prevalence of Drug Use Disorder Among Transgender Veterans	19
In Vivo Imaging Evidence of a Neuroinflammatory Phenotype Among Patients With Opioid Use Disorder	19
Who Gets Treatment And Who Gets Criminalized Racialized Associations Between Cannabis Arrests And Criminal Legal System Referrals To Cannabis Treatment, 1992-2019	19
Liver Disease Among People who Inject drugs: A Prospective Longitudinal Cohort Study Linked to Administrative Hospital Data	19
Maryland Opioid Overdose Deaths From 2018 to 2021: Occupational Pattern and Its Sociodemographic Variations	19
Associations between cannabis use, opioid misuse and severe psychological distress in adolescents: A cross-sectional school-based study	18
Impact of reduced nicotine content on behavioral economic measures of cigarette reinforcement in adolescents who smoke cigarettes	18
Editorial Board	18
Modeling cue-exposure therapy for alcohol use disorder in rhesus monkeys: Effects of putative cognitive enhancers	18
Depression Outcomes Among Women Participating in Worth Transitions	18
School party culture as a driver of cocaine use among Norwegian adolescents: A cross-classified multilevel analysis	18
Assessment of substance exposures in nail clipping samples: A systematic review	18
Trends in overdose deaths involving gabapentinoids and Z-drugs in the United States	18
Secondhand electronic cigarette aerosol in vehicles impacts indoor air quality	18
Prevalence and socio-structural determinants of tobacco exposure in young women: Data from the Healthy Trajectories Initiative (HeLTI) study in urban Soweto, South Africa	18
Associations of sex-related steroid hormones and proteins with alcohol dependence: A United Kingdom Biobank study	18
Structural indices of brain aging in methamphetamine use disorder	18
Violence, policing, and systemic racism as structural barriers to substance use treatment amongst women sex workers who use drugs: Findings of a community-based cohort in Vancouver, Canada (2010–2019)	18
College-based social and situational predictors of real-time prescription drug misuse in daily life	18
The defining characteristic of substance use disorders	18
Editorial Board	18
Tobacco use is associated with low peripheral beta-arrestin 1 levels in major depression: A preliminary report	18
Prenatal alcohol exposure and offspring subsequent alcohol use: A systematic review	18
Adolescent depression symptoms and e-cigarette progression	18
State marijuana policies and vaping associated lung injuries in the US	18
Deficits in consummatory reward relate to severity of cocaine use	17
How has the brain disease model of addiction contributed to tobacco control?	17
Cannabis use and sleep quality in daily life: An electronic daily diary study of adults starting cannabis for health concerns	17
Identifying biomarkers of drug use recurrence using wearable device technologies and phone applications	17
Changes in Opioid Agonist Treatment Initiation Following Voluntary and Mandatory Prescription Drug Monitoring Program Implementation: A Time Series Analysis	17
Assessing inequities in buprenorphine treatment across the care cascade	17
Protecting historically marginalized groups or targeted marketing? A computational analysis of individuals engaging with public and protected cigar-branded tweets	17
Group behavioral activation with and without a smartphone app in intensive outpatient treatment for substance use disorder: A three-arm randomized controlled trial	17
An investigation of multimodal predictors of adolescent alcohol initiation	17
Legality of drug checking equipment in the United States: A systematic legal analysis	17
Exploring Long-Term Trajectories of Quality of Life for People who are Treated With Methadone	17
“I still partly think this is bullshit”: A qualitative analysis of cannabinoid hyperemesis syndrome perceptions among people with chronic cannabis use and cyclic vomiting	17
Different brain oxidative and neuroinflammation status in rats during prolonged abstinence depending on their ethanol relapse-like drinking behavior: Effects of ethanol reintroduction	17
Trends in poisonings involving ketamine in the United States, 2019–2023	17
Editorial Board	17
High Threshold Prescribing Practices Associated With Increased Termination of Care: Results From a Survey of Michigan Buprenorphine Prescribers	17
Emotion Dysregulation Fully Mediates the Relationship between Stress and Impulsivity in Inpatients With Co-Occurring Substance Use and Mental Health Disorders	16
WORKSHOP: NEW APPROACHES TO CULTURALLY APPROPRIATE TREATMENT AND RESEARCH	16
Drug Decriminalization in the United States: Emerging Models, Implementation Experiences and Implications for Health and Racial Equity	16
Untargeted Umbilical Cord Testing to Detect Novel Psychoactive Substances	16
Gender Differences in Smoking Dependence Motives	16
Positive Methamphetamine Urinalysis Result During Treatment Intake is Not Associated With Worst Treatment Outcomes Amongst Opioid Users Initiating Medication-Assisted Opioid Treatment in Rural Communi	16
Using Biomarker Ratios to Distinguish Between Exclusive and Dual Use of Cigarettes, Smokeless Tobacco, and e-Cigarettes	16
Health Justice Coordination for Increased Access to Health and Social Services for People With Drug Use Disorders in Contact With the Criminal Justice System	16
Small Business Program: Implementation of a Technological Solution to Support Treatment for Opioid Use Disorder in the Primary Care Setting	16
Access to Medications for Opioid Use Disorders: A Multi-Site Comparison of Qualitative Evidence With Stakeholders	16
Oud Treatment, Harm Reduction Service Engagement, and Sexually Transmitted Infection Risk Among Men and Women who Use Illicit Opioids in New York City	16
Perceptions of Overdose Response Hotlines Among a Sample of People in Treatment for Substance Use Disorder	16
CAREGIVING AND COPING: ALCOHOL USE DURING THE PANDEMIC IN NEW YORK CITY	16
Incentivized Collaborative Care to Disseminate Contingency Management via Buprenorphine Treatment	16
Trends of Prenatal Substance Exposure: A 10 Year Evaluation of Umbilical Cord Test Outcomes	16
The association between community social vulnerability and prescription opioid availability with individual opioid overdose	16
Erratum to “Sex differences in circulating inflammatory mediators as a function of substance use disorder” [Drug Alcohol Depend. 221 (2021) 108610]	15
Negative affect and craving during abstinence from smoking are both linked to default mode network connectivity	15
Blunt and non-blunt cannabis use associated with cigarette, e-cigarette, and cigar initiation: Findings from the population assessment of tobacco and health (PATH) study	15
Trends in fatal and nonfatal overdose by race among people who inject drugs in Baltimore, Maryland from 1998 to 2019	15
An updated view on the influence of initial opioid prescription characteristics on long-term opioid use among opioid naïve patients	15
FACTORS LINKED WITH PSYCHOLOGICAL DISTRESS IN A DIVERSE SAMPLE OF SUBSTANCE-USING ADULTS IN THE SOUTHEASTERN U.S.	15
Depressive symptoms predict cannabis vaping initiation among young adults	15
Effects of NMDA receptor antagonists on behavioral economic indices of cocaine self-administration	15
Hours high as a proxy for marijuana use quantity in intensive longitudinal designs	15
Daily impulsivity is associated with alcohol use and problems via coping motives, but not enhancement motives	15
Chronic health conditions, acute health events, and healthcare utilization among adults over age 50 in Hawai’i who use cannabis: A matched cohort study	15
Performance-enhancing substance use and criminal offending: A 15-year prospective cohort study	15
Substance use disorders and disparities in hispanic and non-hispanic older adults	15
Nicotine formulations impact reinforcement-related behaviors in a mouse model of vapor self-administration	15
The combined impact of higher-risk on-license venue outlet density and trading hours on serious assaults in night-time entertainment precincts	15
Risk factors for COVID-19 among persons with substance use disorder (PWSUD) with hospital visits – United States, April 2020–December 2020	15
Religiosity and substance use in U.S. adults: Findings from a large-scale national survey	15
Editorial Board	15
Association between gender diversity and substance use experimentation in early adolescents	15
Who participates in the ‘Celebrate Recovery’ mutual-help organization? Results from a National US Investigation	15
Dose-dependent effects of Varenicline on tobacco craving and withdrawal in tobacco smokers with and without schizophrenia	15
Stimulant use, HIV, and immune dysregulation among sexual minority men	15
Assessing the Association Between Increased Student-Adult Connections, Perceptions of School, and Substance Misuse Rates Among Justice-Involved Adolescents	14
Heightened Insula Signal but Reduced Interoceptive Awareness is Linked to Relapse in Opioid Use Disorder: Preliminary Findings	14
HARM REDUCTION SUPPLY DISTRIBUTION VIA VENDING MACHINES: 6-MONTH OUTCOMES FOR A CALIFORNIA VETERANS AFFAIRS HEALTH CARE SYSTEM	14
Latent Class Analysis of Changes in Substance Use and Depressive Symptoms following Naturalistic Psilocybin Use: Results from a Prospective Longitudinal Survey	14
Development and Validation of Machine-Learning Algorithms Predicting Retention, Overdoses, and All-Cause Mortality Among US Military Veterans Treated with Buprenorphine for Opioid Use Disorder	14
10 Hz Excited DLPFC, but Not 1 Hz Inhibited Mofc Induced Smoking Cessation: A Randomized Repetitive Transcranial Magnetic Stimulation Trial	14
The Role of Substance Use on ART Adherence Among Black People With HIV	14
Lifetime and 30-Day Drug Use Associated With Higher by FTND Scores	14